Legend Capital Leads $100M Series C In Innovent Biologics
January 23, 2015 — 22:43 CST
This Data Is Locked!
This area is available only to Subscribers.
Suzhou city, Jiangsu province-based Chinese bio-pharmaceutical firm Innovent Biologics, Inc. has raised US$100 million series C financing led by Legend Capital, according to a company... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
